Abreva Cold Sore & Fever Blister Treatment

Overview Abreva 10% Docosanol Cold Sore Treatment is a nonprescription option designed for cold sores that begin with a tingle. The smooth, white cream combines 10% docosanol and a targeted application method to support early intervention and may help shorten the duration of discomfort when used as directed at the first sign. How it works By engaging with the surface of healthy skin cells, the formula helps form a barrier that may limit the virus’s ability to spread. This approach addresses early sensations such as tingling, burning, itching, and mild pain as a fever blister forms on the lip. Active ingredient: 10% docosanol designed to interfere with viral entry into healthy skin cells. Potential to shorten healing time to about 2.5 days for some users when applied at the first sign. May ease common symptoms including tingling, pain, burning, and itching as the sore develops. FDA-approved nonprescription medicine formulated for quick, targeted lip care. Why people choose Abreva Abreva is a well-known option in the cold sore category and is frequently chosen for on-the-go use. The pump bottle design supports clean, controlled application, making it convenient to reapply whenever needed during the day. Compact pump bottle for easy, on-the-go treatment. HSA and FSA eligible, helping with eligible expenses where applicable. Widely recognized as a leading cold sore treatment, with dermatologist recommendations cited in product materials. Usage guidance: For best results, apply as directed five times daily for up to 10 days. If symptoms persist or worsen, seek medical advice. Always follow the directions on the package. FAQ Q: What is Abreva 10% Docosanol used for? A: A nonprescription cold sore treatment designed to address early symptoms by potentially shortening healing time when applied at the first sign. Q: How should I use Abreva to maximize benefit? A: Apply five times daily for up to 10 days, starting at the first tingle, ensuring clean lips before each applicati